Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1999 May;12(5):499-503.
doi: 10.1016/s0895-7061(99)00018-7.

Effect of luminal angiotensin II receptor antagonists on proximal tubule transport

Affiliations
Comparative Study

Effect of luminal angiotensin II receptor antagonists on proximal tubule transport

A Quan et al. Am J Hypertens. 1999 May.

Abstract

The proximal tubule can endogenously synthesize and secrete luminal angiotensin II at a concentration approximately 100- to 1000-fold higher than that in the systemic circulation. We have recently shown that this endogenously produced and luminally secreted angiotensin II regulates proximal tubule volume reabsorption, which is a reflection of sodium transport within this segment. In this study, we use in vivo microperfusion of angiotensin II receptor antagonists into the lumen of the proximal tubule to examine the role of the luminal AT1 and AT2 receptor in the regulation of volume reabsorption. Systemically administered (intravenous) AT1 and AT2 receptor antagonists, acting through basolateral angiotensin II receptors, have previously been shown to inhibit proximal tubule transport. Luminal perfusion of 10(-6) mol/L Dup 753 (AT1 antagonist) and 10(-6) mol/L PD 123319 (AT2 antagonist) decreased proximal tubule volume reabsorption from 2.94 +/- 0.18 to 1.65 +/- 0.18 and 1.64 +/- 0.19 nL/mm x min, respectively, P < .01. Luminal perfusion of 10(-4) mol/L CGP 42112A, another AT2 antagonist, similarly decreased volume reabsorption to 1.32 +/- 0.36 nL/nm x min, P < .01. The inhibition of transport with AT1 and AT2 antagonist was additive, as luminal perfusion of 10(-6) mol/L Dup 753 plus 10(-6) mol/L 123319 resulted in a decrease in volume reabsorption to 0.41 +/- 0.31 nL/mm x min, P < .001 v control, P < .05 v Dup 753, and P < .01 v PD 123319. These results show that endogenously produced angiotensin II regulates proximal tubule volume transport via both luminal AT1 and AT2 receptors.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Comparison of proximal tubule volume reabsorptive rate (Jv) with luminal perfusion of 10−6 mol/L Dup 753 (AT1 antagonist), 10−6 mol/L PD 123319 (AT2 antagonist), 10−4 mol/L CGP 42112A (AT2 antagonist) and 10−6 mol/L Dup 753 × 10−6 mol/L PD 123319. The inhibition of volume reabsorption noted with Dup 753 and PD 123319 were additive. (*P < .01 compared with control; **P < .001 compared with control; ***P < .05 compared with Dup 753 or CGP 42112A; ‡P < 0.01 compared with PD 123319.)

Similar articles

Cited by

References

    1. Blankley CJ, Hodges JC, Klutcho SR, et al. Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype. J Med Chem. 1991;34:3248–3260. - PubMed
    1. Duncia JV, Chiu AT, Carini DJ, et al. The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives. J Med Chem. 1990;33:1312–1329. - PubMed
    1. Timmermans PBMWM, Wong PC, Chiu AT, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharm Reviews. 1991;45:205–251. - PubMed
    1. Chiu AT, McCall DE, Aldrich PE, et al. [3H]Dup 753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype. Biochem Biophys Res Commun. 1990;172:1195–1202. - PubMed
    1. De Gasparo M, Whitebread S, Mele M, et al. Biochemical characterization of two angiotensin II receptor subtypes in the rat. J Cardiovasc Pharmacol. 1990;16(suppl 4):S31–S35. - PubMed

Publication types